Group One Trading
LXEO icon

Group One Trading’s Lexeo Therapeutics LXEO Stock Holding History

Group One Trading’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.75K Hold
1,109
– – ﹤0.01% 6784
2026
Q2 		$5.16K Sell
1,109
-199
-15% -$1.08K ﹤0.01% 6720
2026
Q1 		$7.51K Sell
1,308
-508
-28% -$3.6K ﹤0.01% 6526
2025
Q4 		$18K Buy
+1,816
New +$16.6K ﹤0.01% 6417

Other funds holding LXEO

Affinity Asset Advisors
Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Group One Trading's LXEO Position: Q3 2026 in Review

Group One Trading held its Lexeo Therapeutics (LXEO) position steady in Q3 2026 at 1,109 shares worth $3.75K. The position accounts for ﹤0.01% of the portfolio, ranked #6784.

Group One Trading first reported a position in LXEO in Q4 2025 and has held it in 4 quarters since. The position peaked at $18K in Q4 2025. 97 funds tracked by Wall St. Rank hold LXEO as of Q3 2026.

  • Group One Trading held 1,109 shares of Lexeo Therapeutics worth $3.75K as of Q3 2026.
  • Group One Trading left its Lexeo Therapeutics share count unchanged in Q3 2026.
  • Lexeo Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #6784 holding.
  • Group One Trading first reported a position in Lexeo Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Group One Trading's Lexeo Therapeutics position peaked at $18K in Q4 2025.
  • 97 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.